Home  »  Finance   »  New Big Money Means BioNTech SE (BNTX) Investors C...

New Big Money Means BioNTech SE (BNTX) Investors Could Reap Benefit

BioNTech SE (NASDAQ: BNTX) is -26.05% lower on its value in year-to-date trading and has touched a low of $100.08 and a high of $188.99 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BNTX stock was last observed hovering at around $116.30 in the last trading session, with the day’s loss setting it -5.21% off its average median price target of $157.54 for the next 12 months. It is also 52.94% off the consensus price target high of $236.06 offered by 18 analysts, but current levels are -12.26% lower than the price target low of $98.96 for the same period.

Currently trading at $111.09, the stock is 2.73% and -6.61% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.15 million and changing -4.48% at the moment leaves the stock -20.71% off its SMA200. BNTX registered -31.03% loss for a year compared to 6-month loss of -29.87%. The firm has a 50-day simple moving average (SMA 50) of $0.92 and a 200-day simple moving average (SMA200) of $1.23.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.

Sponsored

The stock witnessed a -2.77% gain in the last 1 month and extending the period to 3 months gives it a -17.34%, and is 5.65% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.75% over the week and 3.56% over the month.

BioNTech SE (BNTX) has around 4530 employees, a market worth around $26.38B and $13.15B in sales. Current P/E ratio is 4.16 and Fwd P/E is 23.59. Profit margin for the company is 51.10%. Distance from 52-week low is 11.00% and -41.22% from its 52-week high. The company has generated returns on investments over the last 12 months (45.00%).

BioNTech SE (BNTX) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for BioNTech SE (BNTX) is a “Overweight”. 18 analysts offering their recommendations for the stock have an average rating of 2.20, where 7 rate it as a Hold and 1 think it is a “Overweight”. 10 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

BioNTech SE is expected to release its quarterly report on 08/07/2023.The EPS is expected to shrink by -4.70% this year

BioNTech SE (BNTX) Top Institutional Holders

The shares outstanding are 242.60M, and float is at 212.72M with Short Float at 0.90%.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts